You are here

Medical devices: new isn’t always better

There has been fierce opposition to the so-called 'Saatchi Bill', or Medical Innovation Bill, with those opposing it, including leading medical research charities, regulators and doctors calling it a 'quacks' charter', says Sarah Moore

27 January 2015

The Bill seeks to remove patients' rights to redress if a doctor provides treatment that no other responsible body of doctors would give.

Challengers of the Bill have concerns about the future of patient safety, yet doctors can currently safely and rapidly innovate if necessary, as has been demonstrated by recent efforts to produce a treatment for the Ebola virus currently devastating much of West Africa.

Those opposing the Bill have concerns about the future of patient safety.

In the field of medical devices, similar fears persist concerning the lack of appropriate regulations which stand between manufacturer and patient: manufacturers across Europe are still able to fast-track products to market with scant or non-existent clinical evidence in support of them, on the basis of 'substantially equivalent' or predicate devices. This enables manufacturers to innovate incrementally, making reportedly minor changes to the design and materials while the ...

Want to read on?

This article is part of our subscription-based access. Please pick one of the options below to continue.

Already registered? Login to access premium content

SUBSCRIBE for one User

Unlimited access to the entire SJ website for a full year for one user.

  • 10 issues a year delivered to you
  • Digital edition of the magazine for one user – sent to your inbox or accessible through the website
  • Access to premium content on the website
  • Access to the fully searchable online archive of Solicitors Journal, Managing Partner and Private Client Adviser, which spans over 13 years
  • Weekly email newsletter with all the latest news, analysis and features
  • Comment on SJ content and contribute to the SJ community online
  • Advanced search feature
  • Online support
  • Access to SJ app compatible with Android and Apple devices – coming soon!
  • 6 special focuses per year
  • Special offers and discounts on Solicitors Journal and IICJ events

Subscribe

CORPORATE SUBSCRIPTION

Your department or entire firm can subscribe to Solicitors Journal online, providing easy access for all who require it. Discount corporate subscription rates apply, based on number of users.

The Corporate IP Licence includes:

  • Digital copy of the magazine sent to individuals’ inboxes and accessible through the website. Solicitors Journal publishes 10 issues per year
  • Unlimited access to premium content on the website based on IP addresses
  • Unlimited access to the fully searchable online archive of Solicitors Journal, Managing Partner and Private Client Adviser, which spans over 13 years
  • Weekly email newsletter with all the latest news, analysis and features
  • Comment on SJ content and contribute to the SJ community online (username required)
  • Unlimited access to SJ app compatible with Android and Apple devices
  • 6 special focuses per year
  • Special offers and discounts on Solicitors Journal and IICJ events

The Corporate IP Licence is tailored to your firm, making it the most cost effective way for the firm to access Solicitors Journal, and enables the firm to remain compliant with copyright and our Terms and Conditions. This gives you the ability to print and circulate articles within the firm.

To enquire about a Corporate IP Licence for your firm, please contact our Subscriptions Manager on emily.beechey@solicitorsjournal.com.